1. Clinical Overview
Nicotinic acid (Vitamin B3, Niacin) is a water-soluble vitamin and a lipid-modifying agent. At therapeutic doses (500mg and above), it acts as a potent antihyperlipidemic drug, significantly reducing serum levels of low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein (VLDL), triglycerides (TG), and lipoprotein(a) [Lp(a)], while increasing high-density lipoprotein cholesterol (HDL-C). It is also an essential nutrient for NAD/NADP coenzyme synthesis. In the Indian context, it is a cost-effective option for dyslipidemia management, especially for raising HDL-C, but its use is limited by a high incidence of flushing.
| Onset | Duration | Bioavailability |
|---|---|---|
| The lipid-lowering effects begin within 1-4 hours of administration, but significant and sustained reductions in triglycerides and LDL-C are observed after 3-5 days of continuous therapy. The peak effect on plasma lipids occurs after 3-5 weeks. | Approximately 24 hours for lipid-modifying effects after a single dose. Sustained-release formulations have a longer duration. | Rapid and nearly complete (>95%) from the gastrointestinal tract when taken on an empty stomach. Food, particularly hot food/drink, can reduce the rate of absorption and may slightly decrease the intensity of flushing. |
2. Mechanism of Action
Nicotinic acid's lipid-modifying effects are multifactorial and not fully understood. It acts primarily by inhibiting hepatic diacylglycerol acyltransferase 2 (DGAT2), a key enzyme in triglyceride synthesis, leading to reduced hepatic production of VLDL. The subsequent decrease in VLDL catabolism results in lower levels of its byproducts, IDL and LDL. It also enhances the catabolic rate of lipoprotein(a). The HDL-raising effect is mediated by decreasing the hepatic clearance of apolipoprotein A-I, a major component of HDL, via inhibition of the hepatocyte beta-chain ATP synthase receptor.
3. Indications & Uses
- Primary Hypercholesterolemia (Type IIa, IIb)
- Mixed Dyslipidemia (elevated LDL-C & TG)
- Severe Hypertriglyceridemia (Type IV, V)
- To raise HDL-C levels in patients with low HDL
4. Dosage & Administration
Adult Dosage: For dyslipidemia: Initiate at a low dose (100-250 mg once or twice daily) to improve tolerance. Titrate upward gradually over several weeks. The usual maintenance dose is 1-2 g/day, given in 2-3 divided doses with meals. The maximum recommended dose is 3 g/day. For Pellagra: 50-100 mg 3-4 times daily.
Administration: Take with or immediately after a low-fat meal or snack (e.g., an apple, crackers) to reduce gastrointestinal upset and flushing. Avoid taking with hot drinks or alcohol, which can exacerbate flushing. Immediate-release tablets should be swallowed whole with a full glass of water. Do not crush or chew extended-release tablets.
5. Side Effects
Common side effects may include:
- Cutaneous flushing (warmth, redness, itching, tingling of face, neck, ears)
- Pruritus
- Gastrointestinal disturbances (nausea, vomiting, diarrhea, dyspepsia)
- Headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| HMG-CoA Reductase Inhibitors (Statins: Atorvastatin, Rosuvastatin) | Increased risk of myopathy and rhabdomyolysis. | Major |
| Aspirin (low-dose) | Aspirin (325mg given 30 min prior) can reduce the severity of nicotinic acid-induced flushing by inhibiting prostaglandin synthesis. | Moderate (Beneficial) |
| Antihypertensives (especially Vasodilators) | Additive vasodilation may potentiate hypotension and dizziness. | Moderate |
| Bile Acid Sequestrants (Colestyramine, Colestipol) | May bind nicotinic acid in the GI tract, reducing its absorption. Administer nicotinic acid at least 4-6 hours before or after the sequestrant. | Moderate |
| Antidiabetic Agents (Insulin, Sulfonylureas) | Nicotinic acid may increase blood glucose levels, necessitating dose adjustment of antidiabetic drugs. | Moderate |
| Alcohol | Potentiates cutaneous flushing and may increase risk of hepatotoxicity. | Major |
7. Patient Counselling
- DO take the tablet with a low-fat snack (like an apple or crackers) to reduce stomach upset and flushing.
- DO take aspirin (325mg) 30 minutes before your dose if your doctor recommends it to reduce flushing.
- DO report severe or persistent flushing, yellowing of skin/eyes (jaundice), dark urine, or unexplained muscle pain/weakness immediately.
- DONT consume alcohol while on this medication.
- DONT take the medicine with hot drinks or spicy food, as this worsens flushing.
- DONT break, crush, or chew extended-release tablets.
8. Toxicology & Storage
Overdose: Symptoms of severe, acute overdose may include intense flushing, warmth, dizziness, nausea, vomiting, diarrhea, pruritus, sweating, and hypotension. Massive overdose can lead to hepatic toxicity (elevated LFTs, jaundice), hyperglycemia, hyperuricemia, cardiac arrhythmias, and shock.
Storage: Store at room temperature (15-30°C), protected from light, moisture, and excessive heat. Keep the container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the packaging.